The majority of chemoradiation (CRT) trials for locally advanced head and neck squamous cell carcinoma (HNSCC) have relied on platinum-based chemotherapy regimens administered every-3-weeks. However, given the...
http://ift.tt/2gGjWsG
http://ift.tt/2feVoqa
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου